Combination Chemotherapy in Treating Patients With Esophageal Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells. It is not
yet known which regimen of combination chemotherapy is more effective in treating esophageal
cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of two regimens of
combination chemotherapy in treating patients who are undergoing surgery for esophageal
cancer.